慢性脏疾病中的多药和剂量调整:一个横截面研究
Jakob Mokros1, Igor Matyukhin1, Oliver Ritter1,2
1Department of Internal Medicine-Cardiology, Angiology, Nephrology and Pulmology, Brandenburg University Hospital, Brandenburg Medical School (Theodor Fontane), Brandenburg, Germany.
Journal of clinical medicine research
|March 13, 2026
概括
多药在慢性病 (CKD) 患者中在所有阶段都是常见的. 医生正在调整药物剂量,以减少功能,表明对CKD管理需求的认识.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 慢性病 (CKD) 是一个主要的全球健康问题,因糖尿病病例的增加而加剧.
- 有效的CKD管理需要仔细考虑药物使用和剂量调整.
研究的目的:
- 分析慢性病 (CKD) 患者在不同严重程度阶段的药物治疗模式.
- 调查慢性病患者药物剂量调整的频率和适当性.
主要方法:
- 对106名CKD患者的回顾性观察分析.
- 基于2024年病:改善全球结果 (KDIGO) 准则的CKD分期.
- 记录所有服用的药物和记录的剂量调整,以减少功能.
主要成果:
- 平均每位患者使用了11.2种药物,在所有CKD阶段观察到多药性.
- 对于40.19%的患者来说,需要调整剂量以减少功能.
- 对每位患者平均4.6种需要减少剂量的药物进行了适当的剂量调整.
结论:
- 多药在慢性病 (CKD) 的各个阶段都很普遍.
- 观察到的药物剂量调整率表明医生的意识和注意力在慢性病患者的药物治疗管理.
相关概念视频
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
293
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
293
Renal Failure: Dose Adjustments
556
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
556
Chronic Kidney Disease IV: Nursing Management
536
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
536
Chronic Kidney Disease III: Interprofessional Care
578
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
578
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
320
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
320
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
303
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
303


